Log In
BCIQ
Print this Print this
 

DRX-194

  Manage Alerts
Collapse Summary General Information
Company DeuteRx LLC
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationSickle cell disease
Indication DetailsTreat pediatric sickle cell disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today